Why is Pharmaids Pharma falling/rising?

As of 04-Aug, Pharmaids Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 64.67, which reflects a rise of 1.65 or 2.62%. The stock has shown a trend reversal today, gaining after two consecutive days of decline. Despite opening with a loss of 2.21%, it reached an intraday high of Rs 64.9, indicating some recovery. Over the past month, the stock has performed well, with an increase of 11.23%, contrasting with the Sensex's decline of 2.89%. However, the stock has faced challenges, including a significant drop in delivery volume, which fell by 78.3% against the 5-day average, and ongoing operating losses that suggest weak long-term fundamental strength.
Broader market context indicates that while Pharmaids has outperformed the sector today by 2.28%, its year-to-date performance remains negative at -8.24%, compared to the Sensex's positive return of 3.69%. The stock's ability to generate returns has been notable, with a 37.80% increase over the past year, despite the broader market's negative performance of -2.34%. However, the company's weak financial fundamentals, including a negative EBITDA and a high debt-equity ratio, raise concerns about its long-term viability, which could impact investor sentiment moving forward.